RNS Number : 0605Q
AIM
16 February 2023
NOTICE
16/02/2023 - 07:00
NOTICE OF CANCELLATION OF ADMISSION TO TRADING ON AIM
Pursuant to AIM Rule 41 the following securities have been cancelled from trading on AIM with effect from the time and date of this notice.
| 4D PHARMA PLC | ||
| 213800O49VYSXWE2ZD52 | ||
| ORDINARY SHARES OF 0.25P EACH, FULLY PAID | (BJL5BR0)(GB00BJL5BR07) | 4D PHAR/PAR VTG FPD 0.0025 |
If you have any queries or require further information, please contact the company's nominated adviser.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.